BIOMAT Database Logo BIOMAT Database Logo

High blood pressure and oral contraceptives. Changes in plasma renin and renin substrate and in aldosterone excretion. 1968

M A Newton, and J E Sealey, and J G Ledingham, and J H Laragh

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D009641 Norethynodrel A synthetic progestational hormone with actions and uses similar to those of PROGESTERONE. It has been used in the treatment of functional uterine bleeding and ENDOMETRIOSIS. As a contraceptive (CONTRACEPTIVE AGENTS), it has usually been administered in combination with MESTRANOL. 19-Norpregn-5(10)-en-20-yn-3-one, 17-hydroxy-, (17alpha)-,Norethynodrel, (8 alpha)-(+-)-Isomer
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003276 Contraceptives, Oral Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both. Low-Dose Oral Contraceptive,Oral Contraceptive,Oral Contraceptives,Oral Contraceptives, Low-Dose,Oral Contraceptives, Phasic,Contraceptive, Low-Dose Oral,Contraceptive, Oral,Contraceptives, Low-Dose Oral,Contraceptives, Phasic Oral,Low Dose Oral Contraceptive,Low-Dose Oral Contraceptives,Oral Contraceptive, Low-Dose,Oral Contraceptives, Low Dose,Phasic Oral Contraceptives
D004997 Ethinyl Estradiol A semisynthetic alkylated ESTRADIOL with a 17-alpha-ethinyl substitution. It has high estrogenic potency when administered orally, and is often used as the estrogenic component in ORAL CONTRACEPTIVES. 19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-,Ethynyl Estradiol,Estinyl,Ethinyl Estradiol Hemihydrate,Ethinyl Estradiol, (8 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,17 alpha)-Isomer,Ethinyl Estradiol, (8 alpha,9 beta,13 alpha,14 beta)-Isomer,Ethinyl Estradiol, (9 beta,17 alpha)-Isomer,Ethinyl-Oestradiol Effik,Ethinylestradiol Jenapharm,Ethinyloestradiol,Lynoral,Microfollin,Microfollin Forte,Progynon C,Estradiol, Ethinyl,Estradiol, Ethynyl,Ethinyl Oestradiol Effik,Hemihydrate, Ethinyl Estradiol,Jenapharm, Ethinylestradiol
D005260 Female Females

Related Publications

M A Newton, and J E Sealey, and J G Ledingham, and J H Laragh
Plasma renin activity, renin substrate and aldosterone during treatment with various oral contraceptives.
December 1974, The Journal of clinical endocrinology and metabolism,
M A Newton, and J E Sealey, and J G Ledingham, and J H Laragh
Plasma renin activity, aldosterone and sodium excretion in women with high and low casual blood pressure levels.
January 1978, Acta medica Scandinavica,
M A Newton, and J E Sealey, and J G Ledingham, and J H Laragh
Hypertension induced by oral contraceptives containing estrogen and gestagen. Effects on plasma renin activity and aldosterone excretion.
November 1969, Annals of internal medicine,
M A Newton, and J E Sealey, and J G Ledingham, and J H Laragh
Evaluation of plasma levels of renin-aldosterone and blood pressure in women over 35 years treated with new oral contraceptives.
September 2001, Contraception,
M A Newton, and J E Sealey, and J G Ledingham, and J H Laragh
Alteration by oral contraceptives of normal menstrual changes in plasma renin activity, concentration and substrate.
February 1969, Clinical science,
M A Newton, and J E Sealey, and J G Ledingham, and J H Laragh
Oral contraceptives and responsiveness of plasma renin activity and blood pressure in normotensive women.
February 1980, Clinical and experimental hypertension,
M A Newton, and J E Sealey, and J G Ledingham, and J H Laragh
Progestin-dependent effect of oral contraceptives on plasma aldosterone/renin ratio.
November 2012, Clinical biochemistry,
M A Newton, and J E Sealey, and J G Ledingham, and J H Laragh
[Monitoring of plasma renin activity, renin substrate and aldosterone concentrations during treatment with hormonal contraceptives (proceedings)].
July 1977, Archiv fur Gynakologie,
M A Newton, and J E Sealey, and J G Ledingham, and J H Laragh
Oral contraceptives and high blood pressure.
February 1971, Australian and New Zealand journal of medicine,
M A Newton, and J E Sealey, and J G Ledingham, and J H Laragh
Plasma renin concentration, activity and substrate in hypertension caused by oral contraceptives.
June 1972, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!